We've found
1,870
archived clinical trials in
Pain
We've found
1,870
archived clinical trials in
Pain
Internet Intervention for Adolescents With Chronic Pain
Updated: 12/31/1969
Web-MAP 2: Internet Intervention for Adolescents With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Internet Intervention for Adolescents With Chronic Pain
Updated: 12/31/1969
Web-MAP 2: Internet Intervention for Adolescents With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Updated: 12/31/1969
A Single-Center, Double-Blind, Randomized, Dose-Ranging, Placebo Controlled Trial Comparing the Safety, Tolerability and Efficacy of LP-08 With Placebo in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Status: Enrolling
Updated: 12/31/1969
Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Updated: 12/31/1969
A Single-Center, Double-Blind, Randomized, Dose-Ranging, Placebo Controlled Trial Comparing the Safety, Tolerability and Efficacy of LP-08 With Placebo in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS)
Updated: 12/31/1969
Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Combined Behavioral and Analgesic Trial for Fibromyalgia
Updated: 12/31/1969
Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavioral Therapy Versus Health Education) for Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Combined Behavioral and Analgesic Trial for Fibromyalgia
Updated: 12/31/1969
Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavioral Therapy Versus Health Education) for Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Combined Behavioral and Analgesic Trial for Fibromyalgia
Updated: 12/31/1969
Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavioral Therapy Versus Health Education) for Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Combined Behavioral and Analgesic Trial for Fibromyalgia
Updated: 12/31/1969
Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavioral Therapy Versus Health Education) for Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
Updated: 12/31/1969
Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
Status: Enrolling
Updated: 12/31/1969
Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
Updated: 12/31/1969
Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sulfasalazine in Treating Painful Neuropathy
Updated: 12/31/1969
A Single-center, Randomized, Double-blind Clinical Study to Evaluate the Effect of Sulfasalazine on Painful Neuropathy
Status: Enrolling
Updated: 12/31/1969
Study of Sulfasalazine in Treating Painful Neuropathy
Updated: 12/31/1969
A Single-center, Randomized, Double-blind Clinical Study to Evaluate the Effect of Sulfasalazine on Painful Neuropathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comprehensive vs. Assisted Management of Mood and Pain Symptoms
Updated: 12/31/1969
Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) Trial
Status: Enrolling
Updated: 12/31/1969
Comprehensive vs. Assisted Management of Mood and Pain Symptoms
Updated: 12/31/1969
Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mechanisms of Sleep Disruption Hyperalgesia
Updated: 12/31/1969
Mechanisms of Sleep Disruption Hyperalgesia
Status: Enrolling
Updated: 12/31/1969
Mechanisms of Sleep Disruption Hyperalgesia
Updated: 12/31/1969
Mechanisms of Sleep Disruption Hyperalgesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Updated: 12/31/1969
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Status: Enrolling
Updated: 12/31/1969
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Updated: 12/31/1969
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials